Last Price$61.4(0.0%)
Market Cap$7,773.1M
Last Earnings date
Dec'24
Q4 2024
$1.08
6.8% miss
$298.0M
4.3% beat
Next quarter EPS Estimate
$0.97
22.8%YoY
HALO Earnings and Expectations
Revenue
Crunching data... Almost there!
HALO EPS (Earnings Per Share)
Crunching data... Almost there!
HALO Historical Revenue & EPS and Expectations
1Y
3Y
5Y
10Y
Revenue
EPS
HALO Earnings History
| Mar'15 | Jun'15 | Sep'15 | Dec'15 | Mar'16 | Jun'16 | Sep'16 | Dec'16 | Mar'17 | Jun'17 | Sep'17 | Dec'17 | Mar'18 | Jun'18 | Sep'18 | Dec'18 | Mar'19 | Jun'19 | Sep'19 | Dec'19 | Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue actual | $18.7M | $43.4M | $20.8M | $52.2M | $42.5M | $33.3M | $31.9M | $39.0M | $29.6M | $33.8M | $63.7M | $189.6M | $30.9M | $35.2M | $25.6M | $60.2M | $56.9M | $39.1M | $46.2M | $53.7M | $25.4M | $55.2M | $65.3M | $121.7M | $89.0M | $136.5M | $115.8M | $102.0M | $117.3M | $152.4M | $209.0M | $181.5M | $162.1M | $221.0M | $216.0M | $230.0M | $195.9M | $231.4M | $290.1M | $298.0M |
| Revenue estimate | $20.3M | $20.3M | $20.3M | $20.3M | $53.1M | $53.1M | $53.1M | $53.1M | $28.5M | $28.5M | $28.5M | $28.5M | $35.8M | $35.8M | $35.8M | $35.8M | $67.8M | $42.8M | $55.0M | $56.9M | $43.0M | $66.7M | $59.9M | $120.0M | $84.9M | $104.1M | $105.8M | $101.5M | $128.3M | $138.6M | $191.2M | $192.1M | $179.3M | $200.0M | $216.1M | $231.0M | $199.7M | $204.9M | $252.2M | $285.7M |
| Revenue surprise | 7.9% | 114.2% | 2.6% | 157.8% | 20.0% | 37.2% | 40.0% | 26.6% | 3.9% | 18.6% | 123.9% | 566.0% | 13.7% | 1.6% | 28.6% | 68.3% | 16.0% | 8.5% | 15.9% | 5.7% | 41.0% | 17.2% | 9.0% | 1.4% | 4.9% | 31.1% | 9.4% | 0.5% | 8.6% | 9.9% | 9.3% | 5.5% | 9.6% | 10.5% | 0.0% | 0.4% | 1.9% | 12.9% | 15.0% | 4.3% |
| EPS actual | ($0.12) | $0.02 | ($0.19) | $0.03 | ($0.16) | ($0.21) | ($0.23) | ($0.22) | ($0.26) | ($0.23) | $0.02 | $0.87 | ($0.19) | ($0.16) | ($0.19) | ($0.02) | $0.01 | ($0.10) | ($0.17) | ($0.24) | ($0.04) | $0.19 | $0.27 | $0.54 | $0.20 | $0.64 | $1.53 | $0.48 | $0.44 | $0.16 | $0.45 | $0.43 | $0.29 | $0.57 | $0.62 | $0.66 | $0.61 | $0.73 | $1.08 | $1.08 |
| EPS estimate | ($0.14) | ($0.14) | ($0.14) | ($0.14) | ($0.24) | ($0.24) | ($0.24) | ($0.24) | ($0.24) | ($0.24) | ($0.24) | ($0.24) | ($0.25) | ($0.25) | ($0.25) | ($0.25) | $0.01 | ($0.14) | ($0.12) | ($0.18) | ($0.02) | $0.25 | $0.19 | $0.53 | $0.32 | $0.43 | $0.42 | $0.38 | $0.46 | $0.47 | $0.36 | $0.30 | $0.38 | $0.63 | $0.71 | $0.83 | $0.69 | $0.76 | $0.99 | $1.16 |
| EPS surprise | 14.3% | 114.3% | 35.7% | 121.4% | 33.3% | 12.5% | 4.2% | 8.3% | 8.3% | 4.2% | 108.3% | 462.5% | 24.0% | 36.0% | 24.0% | 93.9% | 27.9% | 29.2% | 40.0% | 31.8% | 114.3% | 22.8% | 38.6% | 2.1% | 37.1% | 47.2% | 261.3% | 24.8% | 4.6% | 66.0% | 24.4% | 43.9% | 24.2% | 9.5% | 12.2% | 20.0% | 11.1% | 3.8% | 9.0% | 6.8% |
Overview of financial statements
Income statement
Balance sheet
Cash Flow statement
$298.0M 29.5% YoY
Cost of revenue
$42.1M (19.6%) YoY
Pre-tax income
$178.2M 76.1% YoY
59.8% margin
Competing with HALO Earnings
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Revenue | EPS | Last quarter Revenue growth | Last quarter EPS growth | Last quarter Revenue surprise | Last quarter EPS surprise | Next quarter Revenue growth | Next quarter EPS growth | Last 10 Earnings (how many miss vs beat) | 1Y Fwd Revenue growth | 1Y Fwd EPS growth |
$7,773.1M | $1,015.3M | $3.50 | 29.5% | 63.6% | Beat by 18.2% | Beat by 9.0% | (23.1%) | (11.4%) | Beats: 7 Misses: 3 | 17.2% | 44.6% | |
$124.8B | $11.0B | ($2.06) | 15.7% | (5.6%) | Beat by 8.4% | Miss by 12.9% | (1.7%) | 20.2% | Beats: Misses: | 8.6% | (962.4%) | |
$77.0B | $14.2B | $40.88 | 10.3% | (21.6%) | Beat by 3.1% | Miss by 27.1% | (10.2%) | 9.3% | Beats: 8 Misses: 2 | 2.4% | 3.1% | |
$34.4B | $2,258.9M | ($1.77) | 73.8% | N/A | Beat by 40.1% | Miss by 281.3% | 23.0% | 13.8% | Beats: 7 Misses: 3 | 76.3% | (132.2%) | |
$30.7B | $2,248.2M | ($2.17) | 34.9% | (40.9%) | Beat by 11.3% | Miss by 29.1% | (0.4%) | 45.9% | Beats: 8 Misses: 2 | 28.6% | (26.5%) | |
$24.0B | €2,751.1M | (€3.84) | (19.5%) | (100.0%) | Beat by 5.2% | Miss by 100.0% | (79.9%) | 0.0% | Beats: 5 Misses: 5 | (28.0%) | (182.9%) | |
$14.5B | $2,263.9M | $2.31 | (0.3%) | (58.6%) | Miss by 14.8% | Miss by 50.4% | 22.5% | 132.0% | Beats: 5 Misses: 5 | 35.4% | 144.6% | |
$13.8B | $2,877.4M | $26.45 | 19.7% | 45.9% | Beat by 1.8% | Beat by 3.3% | (0.9%) | (3.0%) | Beats: 7 Misses: 3 | 9.1% | 6.8% | |
$13.4B | $2,850.5M | $2.25 | 15.6% | 490.9% | Beat by 6.2% | Beat by 22.4% | (0.9%) | 7.4% | Beats: 8 Misses: 2 | 10.0% | 48.9% | |
$13.3B | $0.0 | ($0.31) | (100.0%) | 62.6% | undefinedN/A | undefinedN/A | 0.0% | (8.4%) | Beats: 6 Misses: 4 | N/A | 11.4% |
FAQ
1. When was Halozyme Therapeutics, Inc.'s last earnings date?
Halozyme Therapeutics, Inc.'s last earnings date was Dec'24 (Q4 2024).
2. What is Halozyme Therapeutics, Inc.'s EPS, and was there a surprise?
Halozyme Therapeutics, Inc.'s EPS was $1.08, with a 6.8% miss.
3. What is Halozyme Therapeutics, Inc.'s revenue, and was there a surprise?
Halozyme Therapeutics, Inc.'s revenue was $298.0M, with a 4.3% beat.
4. What is Halozyme Therapeutics, Inc.'s next quarter EPS estimate?
Halozyme Therapeutics, Inc.'s next quarter EPS estimate is $0.97, with an expected 22.8% YoY growth.